Is ECRFF or MRK a better dividend investment in 2026?

ECRFF currently yields 1226.99% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: ECRFF offers higher current income.

What is the dividend yield difference between ECRFF and MRK?

ECRFF has a forward dividend yield of 1226.99% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 1223.74 percentage points.

Home › Compare › ECRFF vs MRK

ECRFF vs MRK: Dividend Comparison 2026

ECRFF yields 1226.99% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ECRFF wins by $114625562.07M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ECRFF

● Live price

1226.99%

Share price

$0.16

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$114625562.10M

Annual income

$98,787,646,490,047.14

Full ECRFF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — ECRFF vs MRK

📍 ECRFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ECRFF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ECRFF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ECRFF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ECRFF

Annual income on $10K today (after 15% tax)

$104,294.48/yr

After 10yr DRIP, annual income (after tax)

$83,969,499,516,540.06/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, ECRFF beats the other by $83,969,499,515,732.31/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ECRFF + MRK for your $10,000?

ECRFF: 50%MRK: 50%

100% MRK50/50100% ECRFF

Portfolio after 10yr

$57312781.07M

Annual income

$49,393,823,245,498.72/yr

Blended yield

86.18%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ECRFF

No analyst data

Altman Z

10.2

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ECRFF buys

MRK buys

No recent congressional trades found for ECRFF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricECRFFMRK

Forward yield	1226.99% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$114625562.10M ✓	$30.7K
Annual income after 10y	$98,787,646,490,047.14 ✓	$950.29
Total dividends collected	$113447024.13M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ECRFF vs MRK ($10,000, DRIP)

Year	ECRFF Portfolio	ECRFF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$133,399	$122,699.39	$11,192	$351.54	+$122.2K → ECRFF
2	$1,672,459	$1,529,721.76	$12,524	$392.70	+$1.66M → ECRFF
3	$19,713,342	$17,923,810.51	$14,015	$438.65	+$19.70M → ECRFF
4	$218,540,626	$197,447,349.98	$15,682	$489.96	+$218.52M → ECRFF
5	$2,279,526,776	$2,045,688,306.21	$17,547	$547.23	+$2279.51M → ECRFF
6	$22,381,070,175	$19,941,976,525.31	$19,632	$611.16	+$22381.05M → ECRFF
7	$206,934,887,075	$182,987,141,987.53	$21,963	$682.53	+$206934.87M → ECRFF
8	$1,802,630,728,102	$1,581,210,398,931.51	$24,571	$762.18	+$1802630.70M → ECRFF
9	$14,801,790,289,179	$12,872,975,410,110.06	$27,486	$851.08	+$14801790.26M → ECRFF
10	$114,625,562,099,469	$98,787,646,490,047.14	$30,745	$950.29	+$114625562.07M → ECRFF

ECRFF vs MRK: Complete Analysis 2026

ECRFF — Stock

Cartier Resources Inc. engages in the acquisition and exploration of mining properties in Canada. It explores for gold deposits. The company's flagship project is the Chimo mine property located to the east of Val-d'Or, Quebec. It also holds interest in Benoist, Fenton, Wilson, Cadillac Extension, Dollier, and MacCormack metal deposit projects, which are located in Quebec. The company was incorporated in 2006 and is headquartered in Val-d'Or, Canada.

Full ECRFF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this ECRFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ECRFF vs SCHD ECRFF vs JEPI ECRFF vs O ECRFF vs KO ECRFF vs MAIN ECRFF vs JNJ ECRFF vs ABBV ECRFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.